ad image

ProQR Therapeutics N.V.

1 / 1
ProQR Therapeutics
FDA

ProQR Receives Rare Pediatric Disease Designation from FDA for QR-421a

ProQR Therapeutics

PR-M01-20-NI-044Jan 30, 2020
Tackling Genetic Eye Diseases with Novel RNA Therapies
Ophthalmology

Tackling Genetic Eye Diseases with Novel RNA Therapies

Daniel A. de Boer

ProQR Therapeutics

PAP-Q4-19-CL-027Dec 06, 2019
1 / 1